NCT07486713 2026-03-20Olutasidenib DDI Study in Patients With IDH1 Mutation Positive MalignanciesRigel PharmaceuticalsPhase 4 Recruiting16 enrolled
NCT00045708 2017-10-18A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasNational Cancer Institute (NCI)Phase 1/2 Completed57 enrolled 18 charts